Overview

Dual-Time Point (DTP) FDG PET CT for the Post-Treatment Assessment of Head and Neck Tumors Following Definitive Chemoradiation Therapy

Status:
Recruiting
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to compare the results of a dual time point (standard and delayed) FDG PET/CT of the head and neck before and after chemo-radiation therapy. This is an investigational study. The FDG PET/CT is delivered using FDA approved and commercially available methods. It is considered investigational to use delayed PET/CT scans to study the effects of chemo-radiation treatment. The FDG injections and PET/CT scans (about 1 hour after FDG injection) will be done as part of your standard of care. The delayed (about 3 hours after FDG injection) PET/CT scans will be provided at no cost to you. Up to 50 participants will be enrolled in this study. All will take part at MD Anderson.
Phase:
Early Phase 1
Details
Lead Sponsor:
M.D. Anderson Cancer Center